Insulin, leptin, and adiponectin receptors in colon: Regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 293, Issue 4, 2007, Pages

  Drew, Janice E ^a   Farquharson, Andrew J ^a   Padidar, Sara ^a   Duthie, Garry G ^a   Mercer, Julian G ^a   Arthur, John R ^a   Morrice, Philip C ^a   Barrera, Lawrence N ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Adipokine; Colon cancer; Hormone receptors; In situ hybridization; Obesity; Real time PCR

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ADIPONECTIN; ADIPONECTIN RECEPTOR; DIMETHYLHYDRAZINE; INSULIN; INSULIN RECEPTOR; LEPTIN; LEPTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CANCER MODEL; CANCER RISK; CARCINOGENESIS; COLON; COLON CANCER; CONTROLLED STUDY; DIETARY INTAKE; INSULIN BLOOD LEVEL; LIFESTYLE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TRIACYLGLYCEROL BLOOD LEVEL;

1,2-DIMETHYLHYDRAZINE; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; COLON; MALE; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; RECEPTORS, ADIPONECTIN; RECEPTORS, LEPTIN;

EID: 35348955824     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00231.2007     Document Type: Article

References (53)

1. Archer ZA, Rayner DV, Rozman J, Klingenspor M, Mercer JG. Normal distribution of body weight gain in male Sprague-Dawley rats fed a high-energy diet. Obesity Res 11: 1376-1383, 2003.
2. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase, Rho-, and Rac-dependent signaling pathways. FASEB J 14: 2329-2338, 2000.
3. Aparicio T, Guileau S, Goiot H, Tsocas A, Laigneau JP, Bado A, Sobhani I, Lehy T. Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat coloni mucosa. Gastroenterology 126: 499-510, 2004.
4. Aparicio T, Kotelevets L, Tsocas A, Laigneau JP, Sobhani I, Chastre E, Lehy T. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice nor intestinal tumourigenesis in ApcMin/+ mice. Gut 54: 1136-1145, 2005.
5. Bartsch H, Nair J. Potential role of lipid peroxidation derived DNA damage in human colon carcinogenesis: studies on exocyclic base adducts as stable oxidative stress markers. Cancer Detect Prev 26: 308-312, 2002.
6. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37: 147-151, 1987.
7. Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 63: 2388-2392, 2001.
8. Calle EE, Kaaks R. Overweight obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Rev Cancer 4: 579-591, 2004.
9. Drew JE, Barrett P, Mercer JG, Moar KM, Canet E, Delagrange P, Morgan PJ. Localisation of the melatonin-related receptor in the rodent brain and peripheral tissues. J Neuroendocrinol 13: 453-458, 2001.
10. Durai R, Yang W, Gupta S, Seifalian AM, Winslet MC. The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis 20: 203-220, 2005.
11. Eastwood GLA. Review of gastrointestinal epithelial renewal, and its relevance to the development of adenocarcinomas of the gastrointestinal tract. J Clin Gastroenterol 21, Suppl 1: S1-S11, 1995.
12. Fantuzzi G, Faggioni R. Leptin in regulation of immunity, inflammation and hematopoiesis. J Leukoc Biol 68: 437-436, 2000.
13. Frezza EE, Wachtel MS, Chiriva-Internati M. The influence of obesity on the risk of developing colon cancer. Gut 55: 285-291, 2006.
14. Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23: 963-974, 2004.
15. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131: 3109S-3120S, 2001.
16. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willet WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122: 327-334, 1995.
17. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 361: 512-519, 2003.
18. Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am J Med Sci 323: 140-145, 2002.
19. Hardwick JCH, van der Brink GR, Offerhaus GJ, van Deventer SJH, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121: 79-90, 2001.
20. Hofmann MA, Schiekofer Kanitz M S, Klevesath MS, Joswig M, Lee V, Morcos M, Tritschler H, Ziegler R, Wahl P, Bierhaus A, Nawroth PP. Insufficient glycemic control increases nuclear factor B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 21: 1310-1316, 1998.
21. Hu E, Liang P, Spiefelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703, 1997.
22. Jacobsen H, Poulsen M, Dragsted LO, Ravn-Haren G, Meyer O, Lindercrona RH. Carbohydrate digestibility predicts colon carcinogenesis in azoxymethane-treated rats. Nutr Cancer 55: 163-170, 2006.
23. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60: 91-106, 2001.
24. Karmiris K, Koutroubakis IE, Kouroumalis EA. The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease. Inflamm Bowel Dis 11: 847-855, 2005.
25. Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 12: 100-105, 2006.
26. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556, 2004.
27. Kiunga GA, Raju J, Sabljic N, Bajaj G, Good CK, Bird RP. Elevated insulin receptor expression in experimentally induced colonic tumours. Cancer Lett 211: 145-153, 2004.
28. Knobler H, Benderly M, Boyko V, Behar S, Matas Z, Rubinstein A, Raz I, Wainstein J. Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose. Eur J Endocrinol 154: 87-92, 2006.
29. Le Marchand L, Wilkins LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 57: 4787-4794, 1997.
30. Levin BE, Dunn-Meynell AA. Defense of body wt against chronic caloric restriction in obesity-prone and -resistant rats. Am J Physiol Regul Integr Comp Physiol 278: R231-R237, 2000.
31. Levin BE, Keesey RE. Defense of differing body weight set points in diet-induced obese and resistant rats. Am J Physiol Regul Integr Comp Physiol 274: R412-R419, 1998.
32. Lim JW, Kim H, Kim KH. Expression of Ku70 and Ku80 mediated by NFk-B and cyclooxygenase-2 is related to proliferation of human gastric cancer cells. J Biol Chem 277: 46093-46100, 2002.
33. Liu Z, Uesaka T, Watanabe H, Isakato N. High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Internat J Oncol 19: 1009-1014, 2001.
34. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3: 687-695, 1994.
35. Matsubara C, Nishikawa Y, Yoshida Y, Takamura K. A spectrophotometric method for the determination of free fatty acids in serum using acyl-coenzyme A synthetase and acyl-coenzyme A oxidase. Anal Biochem 130: 128-133, 1983.
36. Molnar D, Decsi T, Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes 28: 1197-1202, 2004.
37. Ogunwobi OO, Beales ILP. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 134: 105-113, 2006.
38. Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, Ishihama K, Saito T, Togashi H, Nakamura T, Kawata YMS. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 11: 3642-3646, 2005.
39. Peterson JI, Young DS. Evaluation of the hexokinase/glucose-6- phosphate dehydrogenase method of determination of glucose in urine. Anal Biochem 23: 301-316, 1968.
40. Schaffler A, Scholmerich J, Buchler C. Mechanisms of disease: adipocytokines, and visceral adipose tissue - emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2: 103-111, 2005.
41. Sitaraman S, Liu X, Charrier L, Gu LH, Ziegler TR, Gewirtz A, Merlin D. Colonic leptin: source of a novel pro-inflammatory cytokine involved in inflammatory bowel disease. FASEB J 18: 696-698, 2004.
42. Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn Study. Diabetes Care 29: 2498-2503, 2006.
43. Tartaglia LA. The leptin receptor. J Lipid Res 272: 6093-6096, 1997.
44. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, Benedetto C, Mussa A. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 5: 421-426, 2000.
45. Tran TT, Naigamwalla D, Oprescu AI, Lam L, McKeown-Evssen G, Bruce WR, Giacca A. Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology 147: 1830-1837, 2006.
46. Trujillo ME, Scherer PE. Adiponectin: journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257: 167-175, 2005.
47. Tsao TS, Tomas E, Murray HE, Hug C, Lee DH, Ruderman NB, Heuser JE, Lodish HF. Role of disulphide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 278: 50810-50817, 2003.
48. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785-1788, 2003.
49. White MF. The IRS-signaling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182: 3-11, 1998.
50. Yamamoto K, Kiyohara T, Murayama Y, Kihara S, Okamoto Y, Funahashi T, Ito T, Nezu R, Tsutsui S, Miyagawa JI, Tamura S, Matsuzawa Y, Shimomura I, Shinomura Y. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 54: 789-796, 2005.
51. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769, 2003.
52. Yildiz BO, Suchard MA, Wong ML, McCann SM, Licinio J. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci USA 101: 10434-10439, 2004.
53. Yoshida I, Suziki A, Vallee M, Matano Y, Masunga T, Zenda T, Shinozaki K, Okada T. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon. Clin Gastroenterol Hepatol 4: 1225-1231, 2006.